A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Aerie Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT01789736

First received: February 9, 2013

Last updated: February 17, 2014

Last verified: February 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2013
Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	February 17, 2014